<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30387023</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1880-4233</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>Breast cancer (Tokyo, Japan)</Title>                <ISOAbbreviation>Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Can quantitative evaluation of mammographic breast density, &quot;volumetric measurement&quot;, predict the masking risk with dense breast tissue? Investigation by comparison with subjective visual estimation by Japanese radiologists.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12282-018-0930-0</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sensitivity to detect breast cancer (BC) is not high in a dense breast due to masking in mammography. To evaluate the breast density, a volumetric measurement system has been recently developed that measures the percent fibroglandular tissue volume (percent FGV, hereafter termed as &quot;FG%&quot;) to the breast volume (BV). This study was designed to investigate whether evaluation using FG% can accurately predict the masking risk by comparing with the current standard method of subjective visual estimation (SVE).</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Using pre-biopsy mammograms of 114 cases histopathologically diagnosed with BC in our facility, SVE based on BI-RADS (5th edition) and volumetric measurements of FG% were conducted. Performance to predict the masking risk was evaluated using the area under the receiver operating characteristic curve (AUC). Relationship between these parameters and the masking risk was evaluated by the adjusted multivariate linear regression analysis.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The AUC of SVE values was 0.742 (95% CI 0.641-0.822), while that of FG% was as significantly low as 0.560 (95% CI 0.427-0.685) (P = 0.0014). The SVE values correlated with the detection of BC in mammography (P = 0.0035), but there was no significant relationship with FG% (P = 0.74). The median BV and FGV were 313 cm<sup>3</sup> (IQR 191-440) and 63 cm<sup>3</sup> (IQR 44-102), respectively. The FGV was comparable to the data for Caucasian women reported in previous studies, but the BV was one-half of the previous data.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The current volumetric measurement system to evaluate FG% to BV was found to be insufficient in the performance to predict the masking risk in Japanese women with relatively small-sized breasts.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Oiwa</LastName>                    <ForeName>Mikinao</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3446-1131</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan. m.oiwa@nnh.hosp.go.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Endo</LastName>                    <ForeName>Tokiko</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, National Hospital Organization Higashi Nagoya Hospital, 5‑101 Umemorizaka, Meito‑ku, Nagoya, 465-8620, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Suda</LastName>                    <ForeName>Namiko</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Morita</LastName>                    <ForeName>Takako</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sato</LastName>                    <ForeName>Yasuyuki</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kawasaki</LastName>                    <ForeName>Tomonori</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Advanced Diagnosis, National Hospital Organization Division of Pathology, Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ichihara</LastName>                    <ForeName>Shu</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Advanced Diagnosis, National Hospital Organization Division of Pathology, Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>01</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Japan</Country>            <MedlineTA>Breast Cancer</MedlineTA>            <NlmUniqueID>100888201</NlmUniqueID>            <ISSNLinking>1340-6868</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Japanese</Keyword>            <Keyword MajorTopicYN="N">Mammography</Keyword>            <Keyword MajorTopicYN="N">Masking</Keyword>            <Keyword MajorTopicYN="N">Volumetric measurement</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30387023</ArticleId>            <ArticleId IdType="doi">10.1007/s12282-018-0930-0</ArticleId>            <ArticleId IdType="pii">10.1007/s12282-018-0930-0</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>